TY - JOUR
T1 - Recombinant interleukin-19 suppresses the formation and progression of experimental abdominal aortic aneurysms
AU - Tanaka, Hiroki
AU - Xu, Baohui
AU - Xuan, Haojun
AU - Ge, Yingbin
AU - Wang, Yan
AU - Li, Yankui
AU - Wang, Wei
AU - Guo, Jia
AU - Zhao, Sihai
AU - Glover, Keith J.
AU - Zheng, Xiaoya
AU - Liu, Shuai
AU - Inuzuka, Kazunori
AU - Fujimura, Naoki
AU - Furusho, Yuko
AU - Ikezoe, Toru
AU - Shoji, Takahiro
AU - Wang, Lixin
AU - Fu, Weiguo
AU - Huang, Jianhua
AU - Unno, Naoki
AU - Dalman, Ronald L.
N1 - Publisher Copyright:
© 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2021/9/7
Y1 - 2021/9/7
N2 - BACKGROUND: Interleukin-19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin-19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10-to 12-week-old male mice via intra-aortic elastase infusion. Influence and potential mechanisms of interleukin-19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin-19 expression in both human and experimental AAAs. In mice, interleukin-19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth-muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin-19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin-19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin-19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C-C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine-expressing helper or cytotoxic T-cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin-19–treated mice. Interleukin-19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin-19 may influence the development and progression of AAAs.
AB - BACKGROUND: Interleukin-19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin-19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10-to 12-week-old male mice via intra-aortic elastase infusion. Influence and potential mechanisms of interleukin-19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin-19 expression in both human and experimental AAAs. In mice, interleukin-19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth-muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin-19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin-19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin-19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C-C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine-expressing helper or cytotoxic T-cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin-19–treated mice. Interleukin-19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin-19 may influence the development and progression of AAAs.
KW - Abdominal aortic aneurysm
KW - Angiogenesis
KW - Cytokines
KW - Interleukin-19
KW - Macrophages
UR - http://www.scopus.com/inward/record.url?scp=85115235618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115235618&partnerID=8YFLogxK
U2 - 10.1161/JAHA.121.022207
DO - 10.1161/JAHA.121.022207
M3 - Article
C2 - 34459250
AN - SCOPUS:85115235618
SN - 2047-9980
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 17
M1 - e022207
ER -